Spinal Bulbar Muscular Atrophy Treatment Market Size And Share

  • Report Code : TIPRE00013514
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Análisis de la cuota de mercado y oportunidades del tratamiento de la atrofia muscular bulbar espinal (2025-2031)

Buy Now

Spinal Bulbar Muscular Atrophy Treatment Market Report Spinal Bulbar Muscular Atrophy Treatment Market Scope and Analysis Spinal Bulbar Muscular Atrophy Treatment Market Size and Share

Spinal Bulbar Muscular Atrophy Treatment Market Report Analysis

Spinal Bulbar Muscular Atrophy Treatment Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • GlaxoSmithKline plc.
  • AbbVie Inc.
  • Takeda Pharmaceutical Company Limited
  • Century Pharmaceuticals Ltd
  • Johnson and Johnson
  • Astellas Pharma
  • Pfizer Inc.
  • Boehringer Ingelheim International GmbH
  • Sanofi

Regional Overview

  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
  • Medio Oriente y África

Market Segmentation

By Clase de medicamento
  • inhibidores de la 5-reductasa
By Agonistas de la hormona liberadora de gonadotropina
  • GnRH
By Canal de Distribución
  • Hospitales
  • Clínicas Ortopédicas
  • Centros de Cirugía Ambulatoria
By Geografía
  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central